Carlo Pozzilli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Shift of multiple sclerosis onset towards older age	JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY	2022
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability	EUROPEAN JOURNAL OF NEUROLOGY	2022
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study	MULTIPLE SCLEROSIS	2022
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register	NEUROLOGICAL SCIENCES	2022
Italian translation and validation of fatigue symptoms and impacts questionnaire in relapsing multiple sclerosis (FSIQ-RMS)	NEUROLOGICAL SCIENCES	2022
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study	NEUROLOGY AND THERAPY	2022
Eating Hubs in Multiple Sclerosis: Exploring the Relationship Between Mediterranean Diet and Disability Status in Italy	FRONTIERS IN NUTRITION	2022
Relation of sensorimotor and cognitive cerebellum functional connectivity with brain structural damage in patients with multiple sclerosis and no disability	EUROPEAN JOURNAL OF NEUROLOGY	2022
Evaluation of Disability Progression in Multiple Sclerosis via Magnetic-Resonance-Based Deep Learning Techniques	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2022
Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with natalizumab: a multicenter, observational study	NEUROLOGICAL SCIENCES	2022
Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register	MULTIPLE SCLEROSIS	2022
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus	JOURNAL OF NEUROLOGY	2021
Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients	FRONTIERS IN NEUROLOGY	2021
A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis	JOURNAL OF NEUROLOGY	2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies	THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS	2021
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration	JOURNAL OF NEUROLOGY	2021
Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis	NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION	2021
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis	AJNR, AMERICAN JOURNAL OF NEURORADIOLOGY	2021